Serum homocysteine and asymmetric dimethylarginine levels in patients with premature ovarian failure: a prospective controlled study.

Gulhan I., Bozkaya G., Bilgir F., Kebapcilar L., Bilgir O., Kavrut M., ...Daha Fazla

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, cilt.27, sa.8, ss.568-71, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 27 Sayı: 8
  • Basım Tarihi: 2011
  • Doi Numarası: 10.3109/09513590.2010.502273
  • Dergi Adı: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.568-71
  • Anahtar Kelimeler: Premature ovarian failure, homocysteine, asymmetric dimethylarginine, HORMONE REPLACEMENT THERAPY, CORONARY-HEART-DISEASE, BONE-MINERAL DENSITY, PLASMA HOMOCYSTEINE, POSTMENOPAUSAL WOMEN, MENOPAUSAL STATUS, ENDOTHELIAL DYSFUNCTION, VASCULAR-DISEASE, VITAMIN STATUS, RISK-FACTOR
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objective. Objective. To investigate serum homocysteine and asymmetric dimethylarginine (ADMA) levels in patients with premature ovarian failure (POF).